As a researcher, publishing your work is an important step in enhancing your academic career and ensuring your work has a wider impact. At BMJ, we are with you at every step of your publication journey and at any stage of your career. We can help you to optimise the presentation and impact of your work, and to disseminate your findings to the people who need to read it.

Publishing in one of our fully open access or transformative journals complies with policies set by funders (including Plan S), institutions and governments.

Options to publish your research open access:

Fully open access journals

Transformative journals

Hybrid  journals

The  BMJ

Explore our journals in oncology

Acceptance rate: 27% Time to first decision: 36 days Citescore: 14.3 Journal Impact Factor: 12.469 JIF Rank (Oncology):                25/245	Acceptance rate: 43% Time to first decision*: 32 days Citescore: 3.9 Journal Impact Factor: 3.007 JIF Rank (Medical, General & Internal): 85/172 *without review	Launched in 2022	Acceptance rate: 32% Time to first decision: 34 days Citescore: 5.2 Journal Impact Factor: 4.661 JIF Rank (Obstetrics & Gynecology): 13/85	Newly launched!

Oncology: 2022 open access highlights

Most read open access articles published in 2022:

Our open access content received on average 7 times more views than other content.

• Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study | Journal for ImmunoTherapy of Cancer
• Ethiopian women’s sexual experiences and coping strategies for sexual problems after gynaecological cancer treatment: a qualitative study | BMJ Open
• Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment | Journal for ImmunoTherapy of Cancer
• Immuno-oncology trends: preclinical models, biomarkers, and clinical development | Journal for ImmunoTherapy of Cancer
• What drives cancer clinical trial accrual? An empirical analysis of studies leading to FDA authorisation (2015–2020) | BMJ Open

Top mentioned open access articles published in 2022:

Ready to get started with your paper?

Resources for every stage of your publishing journey with BMJ

Introducing our latest open access journals

		BMJ Mental Health (formerly Evidence-Based Mental Health) is an open access journal supporting mental health researchers and practitioners in improving patient and carer outcomes. The journal facilitates multidisciplinary collaboration among psychiatrists, psychologists and other mental health professionals, encourages debate on clinically relevant topics, and informs real world practice.
		Launching April 2023 BMJ Public Health is an open access, peer-reviewed journal covering all aspects of public health, from global issues such as the impact of climate change on population health, to studies conducted at a local level.   Sign up to receive eAlerts

Stay up to date with the latest research in oncology

      Sign up to receive eAlerts